A specialist HIV pharmaceutical company majority owned by GlaxoSmithKline has launched a Federal Court case accusing competitor Gilead Sciences of selling an HIV-fighting drug that […]
Australian drug maker Juno Pharmaceuticals has hit back at claims it is infringing the patent for US-based Pfizer’s post-operative pain killer Dynastat, saying the patent […]
Pfizer, maker of the blockbuster rheumatoid arthritis biologic Enbrel, has taken generic drug maker Sandoz to court for information on its Enbrel biosimilar, after winning […]
A class action against the NSW government over a contractor who took private details of 130 ambulance workers to on-sell to personal injury law firms, […]
Mobility equipment provider Country Care Group will fight for the dismissal of three charges brought by federal prosecutors in the country’s first criminal cartel case […]
A Federal Court judge has reversed a prior ruling expanding the class in a lawsuit against Johnson & Johnson unit Ethicon over allegedly defective pelvic […]
An impending judgment in the long-running class action against Johnson & Johnson unit Ethicon over allegedly defective pelvic mesh implants has sent the parties scrambling […]
Cosmetic Institute director Dr Eddy Dona has flagged that he may drag insurers of his now collapsed medical chain into a class action brought against […]
UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends […]
Former health minister and Prime Trust director Michael Wooldridge wants court approval to manage four corporations, despite a recent ruling from the Full Federal Court […]